- Patient factors domain of MeNTS-METs score.
| Variables | 1 | 2 | 3 | 4 | 5 |
|---|---|---|---|---|---|
| Patient factors | |||||
| Age | <20 | 21-40 | 41-50 | 51-65 | >65 |
| Lung disease (asthma, COPD, and CF) | None | - | - | Minimal (rare inhaler) | >Minimal |
| Obstructive sleep apnea | Not present | - | - | Mild/moderate (no CPAP) | On CPAP |
| CV disease (HTN, CHF, and CAD) | None | Minimal (no meds) | Mild (one med) | Moderate (2 meds) | Severe (≥3 meds) |
| Diabetes | None | - | Mild (no meds) | Moderate (PO meds only) | >Moderate (insulin) |
| Immuno-compromised* | No | - | - | Moderate | Severe |
| ILI symptoms† | None (asymptomatic) | - | - | - | Yes |
| Exposure to a COVID-19 person in past 14 days | No | Probably not | Possibly | Probably | Yes |
| METs‡ | =9.89 | ≥7 and <9.89 | - | ≥4 and <7 | <4 |
↵* Hematologic malignancy, stem cell transplant, solid organ transplant, active/recent cytotoxic chemotherapy, anti-TNFa or other immunosuppressants, >20 mg prednisone equivalent/day, congenital immunodeficiency, hypogammaglobulinemia on intravenous immunoglobulin, AIDS.
↵† Such as fever, cough, sore throat, body aches, and diarrhea.
↵‡ Maximum Duke activity status index: 58.2 [(0.43×DASI+9.6)/3.5] - [(0.43×58.2+9.6)/3.5]=9.89 (maximum METs value calculated according to the equation).
CAD: coronary artery disease, CF: cystic fibrosis, CHF: congestive heart failure, CPAP: continuous positive airway pressure, CV: cardiovascular, HTN: hypertension, ILI: influenza-like illness, med: medication, MeNTS: medically necessary, time-sensitive, METs: metabolic equivalents, PO: by mouth